subgroup of
drug)
→
ReceivesAction
→
compared with placebo
| Typicality: | 0.419 |
| Saliency: | 0.320 |
| in some trials | 3 | location |
| generally | 2 | manner |
| for ease | 2 | purpose |
| new drug → be compared with → placebo | 4 |
| new drug → be compared to → placebo | 4 |
| new drug → get → placebo | 3 |
| negative | neutral | positive |
| 0.155 | 0.720 | 0.125 |
| Raw frequency | 11 |
| Normalized frequency | 0.320 |
| Modifier score | 0.600 |
| Perplexity | 87.112 |